Gingival Langerhans cells regulate plasticity of P. gingivalis-specific T cells
Gingival Langerhans cells regulate plasticity of P. gingivalis-specific T cells
批准号:
9165057
负责人:
MASSIMO COSTALONGA
金额:
$22.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2018-06-30
关键词:
AblationAdultAffectAntigen-Presenting CellsAntigensAutomobile DrivingCD4 Positive T LymphocytesCellsCervical lymph node groupCharacteristicsChronicClonal ExpansionDataDentalDevelopmentDiseaseEcosystemEngineeringEnvironmentEpithelialEpitheliumEpitopesGenetic CrossesGingivaGoalsGram-Negative BacteriaGrantHelper-Inducer T-LymphocyteHumanImmuneImmune responseIndividualInfectionInflammatoryInterferon Type IIInterleukin-17KineticsKnowledgeLangerhans cellLesionLeukocytesMHC Class II GenesMediatingMicrobeMicrobial BiofilmsModelingMolecularMouse StrainsMusOralPathologyPatientsPeriodontal DiseasesPeriodontitisPeriodontiumPhenotypePlayPopulationPorphyromonas gingivalisPositioning AttributeProductionReagentRegulatory T-LymphocyteReporterReportingResearchResearch PersonnelRoleShapesSignal TransductionStagingStructure of gingival sulcusSubmucosaSurfaceT-LymphocyteTestingTherapeutic InterventionTimeTissuesTooth LossTooth structureUnited StatesVaccinesVirulence FactorsWorkalveolar bonebonecostcytokinegingipainin vivolymph nodesmicrobialmouse modelnoveloral infectionosteoclastogenesispathogenpreventprogramsresponsetargeted treatmenttoolunnecessary treatment
中文摘要
7. 项目摘要/摘要
英文摘要
7. PROJECT SUMMARY / ABSTRACT
Periodontitis is a chronic inflammatory disease that affects 30-40% of the U.S. population. It is the leading
cause of periodontal tissue destruction and tooth loss. Understanding its immunopathogenesis is important for
developing cell-mediated vaccines and because we cannot accurately predict the development of periodontitis,
leading dental patients to undergo unnecessary treatment. What is known is that activated CD4+ T helper cells
(Th) contribute to alveolar bone destruction by influencing osteoclastogenesis. What remains unknown is the
relative roles of mucosal antigen presenting cells on the priming and plasticity of CD4+ T cells after
encountering a keystone pathogen. Our long-range goal is to identify and characterize the components of the
local immune response to periodontal pathogens that predisposes an individual to periodontitis. Our current
objective is to determine the kinetics of differentiation and plasticity of gingival Th17 and iTreg cells that is
modulated by Langerhans cells (LCs) after oral colonization with Porphyromonas gingivalis (Pg). We have
preliminary data that suggests that absence of LCs does not alter the clonal expansion of activated CD4+ T
cells but prevents the differentiation of Th17 cells specific for Pg gingipain virulence factors. We hypothesize
that persistent oral colonization with Pg induces mucosal antigen presenting cells (i.e. LCs) to differentially
favor the late developmental re-programming of gingival Th17 cells into IFN-γ expressing Th cells and iTregs
into IL-17A- or IFN-γ-expressing cells. To test our hypothesis, we will first determine the kinetics of Th17 and
iTreg persistence and conversion to IFN-γ− or IL-17A-expressing cells in the gingiva of mice following oral
inoculation with Pg. Second, determine the role of oral LCs in driving Th17 and iTreg plasticity following oral
colonization with Pg. To the best of our knowledge, we are the first group in the world to have engineered an I-
Ab tetramer displaying native epitopes from Pg, which will be used to track Pg-specific CD4+ T cells after
targeted ablation of LCs. Our strategy employs genetic crossing of reporter-mouse strains that unequivocally
and permanently mark the developmental fate of Th17 and iTregs. We expect to determine the role of LCs as
regulators of the late developmental re-programming of Pg-specific Th17 and iTreg cells either in the gingiva or
cervical lymph nodes. With a deeper understanding of the mechanisms initiating periodontal disease comes
opportunities through therapeutic interventions to manipulate key steps and mitigate against or prevent
periodontitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Calprotectin and CD69 affect regulatory T cell responses in periodontal disease
-
批准号:10353423
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2021
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Calprotectin and CD69 affect regulatory T cell responses in periodontal disease
-
批准号:10217424
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2021
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Calprotectin-mediated CD69 signaling in periodontitis
-
批准号:10298399
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2021
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Calprotectin-mediated CD69 signaling in periodontitis
-
批准号:10437044
-
项目类别:
-
资助金额:$39.86万
-
财政年份:2021
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Calprotectin-mediated CD69 signaling in periodontitis
-
批准号:10618409
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2021
-
负责人:MASSIMO COSTALONGA
-
依托单位:
MHC-II deficient Langerhans cells with compensatory Tc17 plasticity in oral candidiasis
-
批准号:10194461
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2020
-
负责人:MASSIMO COSTALONGA
-
依托单位:
MHC-II deficient Langerhans cells with compensatory Tc17 plasticity in oral candidiasis
-
批准号:10056498
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2020
-
负责人:MASSIMO COSTALONGA
-
依托单位:
P. gingivalis-specific T cells in mice prone and resistant to periodontitis
-
批准号:8654333
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2013
-
负责人:MASSIMO COSTALONGA
-
依托单位:
P. gingivalis-specific T cells in mice prone and resistant to periodontitis
-
批准号:8507349
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2013
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Tracking Mucosal T cells to Commensal Microbes in Vivo
-
批准号:6845376
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2004
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Tracking Mucosal T cells to Commensal Microbes in Vivo
-
批准号:6728031
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2004
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Tracking Mucosal T cells to Commensal Microbes in Vivo
-
批准号:7011202
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2004
-
负责人:MASSIMO COSTALONGA
-
依托单位:
Trafficking Mucosal APCs: Differential Responses to Commensals and Pathogens
-
批准号:8112180
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2001
-
负责人:MASSIMO COSTALONGA
-
依托单位:
海外基金